Format

Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2019 May 16. doi: 10.1007/s00259-019-04324-5. [Epub ahead of print]

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Author information

1
Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zzale Spedali Civili, 1, 25123, Brescia, Italy. pilottoandreae@gmail.com.
2
Parkinson's Disease Rehabilitation Centre, FERB ONLUS - S. Isidoro Hospital, Trescore Balneario, BG, Italy. pilottoandreae@gmail.com.
3
Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zzale Spedali Civili, 1, 25123, Brescia, Italy.
4
Stroke Unit, Azienda Socio Sanitaria Territoriale Spedali Civili, Spedali Civili Hospital, Brescia, Italy.
5
Nuclear Medicine Unit, University of Brescia, Brescia, Italy.
6
Department of Medical Imaging, Geneva University Hospital, Geneva, Switzerland.
7
Parkinson's Disease Rehabilitation Centre, FERB ONLUS - S. Isidoro Hospital, Trescore Balneario, BG, Italy.
8
Department of Neuroscience Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.
9
Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
10
IRCCS ospedale Policlinico San Martino, Genoa, Italy.
11
Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy.
12
Nuclear Medicine Unit, Poliambulanza Hospital, Brescia, Italy.
13
Nuclear Medicine Unit San Raffaele Hospital, Division of Neuroscience San Raffaele Scientific Institute, Milan, Italy.

Abstract

PURPOSE:

The aim of the study was to evaluate extrastriatal dopaminergic and serotonergic pathways in patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB) using 123I-FP-CIT SPECT imaging.

METHODS:

The study groups comprised 56 PD patients without dementia, 41 DLB patients and 54 controls. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. Binding in nigrostriatal and extrastriatal regions of interest was calculated in each patient from spatially normalized images. The occipital-adjusted specific to nondisplaceable binding ratio (SBR) in the different regions was compared among the PD patients, DLB patients and controls adjusting for the effects of age, sex, disease duration and serotonergic/dopaminergic treatment. Covariance analysis was used to determine the correlates of local and long-distance regions with extrastriatal 123I-FP-CIT deficits.

RESULTS:

Both PD and DLB patients showed lower 123I-FP-CIT SPECT SBR in several regions beyond the nigrostriatal system, especially the insula, cingulate and thalamus. DLB patients showed significantly lower 123I-FP-CIT SBR in the thalamus than controls and PD patients. Thalamic and cingulate 123I-FP-CIT SBR deficits were correlated, respectively, with limbic serotonergic and widespread cortical monoaminergic projections only in DLB patients but exhibited only local correlations in PD patients and controls.

CONCLUSION:

PD and DLB patients both showed insular dopamine deficits, whereas impairment of thalamic serotonergic pathways was specifically associated with DLB. Longitudinal studies are necessary to determine the clinical value of the assessment of extrastriatal 123I-FP-CIT SPECT.

KEYWORDS:

123I-FP-CIT SPECT; Dementia with Lewy bodies; Dopamine; Parkinson’s disease; Serotonin

PMID:
31098748
DOI:
10.1007/s00259-019-04324-5

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center